Liu C, Lu I, Wang L, Chen J, Li Y, Yang C
Mol Pain. 2021; 17:17448069211045211.
PMID: 34517736
PMC: 8642049.
DOI: 10.1177/17448069211045211.
Zhang Y, Yan F, Li S, Wang Y, Ma Y
Int J Nurs Sci. 2021; 8(1):30-37.
PMID: 33575442
PMC: 7859554.
DOI: 10.1016/j.ijnss.2020.12.009.
Himmerich H, Patsalos O, Lichtblau N, Ibrahim M, Dalton B
Front Psychiatry. 2019; 10:30.
PMID: 30792669
PMC: 6374304.
DOI: 10.3389/fpsyt.2019.00030.
Felger J
Curr Neuropharmacol. 2017; 16(5):533-558.
PMID: 29173175
PMC: 5997866.
DOI: 10.2174/1570159X15666171123201142.
Jacobsen J, Buisman-Pijlman F, Mustafa S, Rice K, Hutchinson M
Neuropharmacology. 2017; 128:460-473.
PMID: 28947376
PMC: 7387100.
DOI: 10.1016/j.neuropharm.2017.09.028.
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.
Felger J, Treadway M
Neuropsychopharmacology. 2016; 42(1):216-241.
PMID: 27480574
PMC: 5143486.
DOI: 10.1038/npp.2016.143.
Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.
Felger J, Miller A
Front Neuroendocrinol. 2012; 33(3):315-27.
PMID: 23000204
PMC: 3484236.
DOI: 10.1016/j.yfrne.2012.09.003.
HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.
Hauser K, El-Hage N, Stiene-Martin A, Maragos W, Nath A, Persidsky Y
J Neurochem. 2006; 100(3):567-86.
PMID: 17173547
PMC: 4305441.
DOI: 10.1111/j.1471-4159.2006.04227.x.
Neurobehavioral effects of interferon therapy.
Valentine A, Meyers C
Curr Psychiatry Rep. 2005; 7(5):391-5.
PMID: 16216160
DOI: 10.1007/s11920-005-0042-3.
Effect of beta-endorphin and cortisol on the PHA stimulated lymphoblastogenesis.
Yang I, Yoon H, Cho K, Kim K, Kim S, Choi Y
Korean J Intern Med. 1986; 1(1):98-103.
PMID: 15759384
PMC: 4534891.
DOI: 10.3904/kjim.1986.1.1.98.
Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
Raison C, Demetrashvili M, Capuron L, Miller A
CNS Drugs. 2005; 19(2):105-23.
PMID: 15697325
PMC: 1255968.
DOI: 10.2165/00023210-200519020-00002.
Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
Makino M, Kitano Y, Komiyama C, Hirohashi M, Takasuna K
Br J Pharmacol. 2000; 130(6):1269-74.
PMID: 10903965
PMC: 1572192.
DOI: 10.1038/sj.bjp.0703432.
Effect of interferon-alpha on DOI-induced wet-dog shakes in rats.
Kugaya A, Kagaya A, Uchitomi Y, Yokota N, Yamawaki S
J Neural Transm (Vienna). 1996; 103(8-9):947-55.
PMID: 9013388
DOI: 10.1007/BF01291785.
Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat.
Katafuchi T, Take S, Hori T
J Physiol. 1993; 465:343-57.
PMID: 8229839
PMC: 1175433.
DOI: 10.1113/jphysiol.1993.sp019680.
Interferon-alpha in malignant and viral diseases. A review.
Dorr R
Drugs. 1993; 45(2):177-211.
PMID: 7681371
DOI: 10.2165/00003495-199345020-00003.
Interferonemia and autism.
Stubbs G
J Autism Dev Disord. 1995; 25(1):71-3.
PMID: 7608036
DOI: 10.1007/BF02178169.
Regulation of the in vitro antibody response by neuroendocrine hormones.
Johnson H, Smith E, Torres B, Blalock J
Proc Natl Acad Sci U S A. 1982; 79(13):4171-4.
PMID: 6287470
PMC: 346599.
DOI: 10.1073/pnas.79.13.4171.
Hormones and the immune response.
Bhalla A
Ann Rheum Dis. 1989; 48(1):1-6.
PMID: 2647048
PMC: 1003666.
DOI: 10.1136/ard.48.1.1.
Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities.
Adams F, Fernandez F, Mavligit G
J Neurooncol. 1988; 6(4):355-9.
PMID: 2464673
DOI: 10.1007/BF00177432.
Neuromodulative actions of cytokines.
Blatteis C
Yale J Biol Med. 1990; 63(2):133-46.
PMID: 2205054
PMC: 2589308.
